LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 74.50 | 770.25 | 8794 | 10991 | 0.8001 | 0.8870 | MN20160304_L02 | H17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 74.50 | 770.25 | 10693 | 10991 | 0.9728 | 0.9857 | MN20160304_L02 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 76.75 | 770.25 | 9182 | 11262 | 0.8152 | 0.8972 | MN20160304_L02 | H17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 76.75 | 770.25 | 10930 | 11262 | 0.9704 | 0.9846 | MN20160304_L02 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 78.98 | 770.25 | 9493 | 11518 | 0.8242 | 0.9033 | MN20160304_L02 | H17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 78.98 | 770.25 | 11442 | 11518 | 0.9934 | 0.9966 | MN20160304_L02 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 81.20 | 770.25 | 10029 | 11766 | 0.8523 | 0.9204 | MN20160304_L02 | H17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 81.20 | 770.25 | 11889 | 11766 | 1.0104 | 1.0053 | MN20160304_L02 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 83.42 | 770.25 | 10327 | 12031 | 0.8583 | 0.9244 | MN20160304_L02 | H17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 83.42 | 770.25 | 12334 | 12031 | 1.0251 | 1.0125 | MN20160304_L02 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 85.64 | 770.25 | 10681 | 12287 | 0.8693 | 0.9311 | MN20160304_L02 | H17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 85.64 | 770.25 | 12663 | 12287 | 1.0306 | 1.0151 | MN20160304_L02 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 87.86 | 770.25 | 11079 | 12543 | 0.8833 | 0.9393 | MN20160304_L02 | H17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 87.86 | 770.25 | 13166 | 12543 | 1.0496 | 1.0242 | MN20160304_L02 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 3.21 | 770.25 | 924 | 904 | 1.0214 | 1.1913 | MN20160304_L02 | C03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 3.21 | 770.25 | 768 | 904 | 0.8490 | -0.0125 | MN20160304_L02 | H18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 5.44 | 770.25 | 1032 | 1012 | 1.0190 | 1.0977 | MN20160304_L02 | C03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 5.44 | 770.25 | 839 | 1012 | 0.8284 | 0.2417 | MN20160304_L02 | H18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 7.66 | 770.25 | 1126 | 1090 | 1.0330 | 1.1340 | MN20160304_L02 | C03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 7.66 | 770.25 | 896 | 1090 | 0.8220 | 0.3524 | MN20160304_L02 | H18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 10.06 | 770.25 | 1193 | 1218 | 0.9791 | 0.9371 | MN20160304_L02 | C03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 10.06 | 770.25 | 974 | 1218 | 0.7993 | 0.4257 | MN20160304_L02 | H18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 12.28 | 770.25 | 1277 | 1358 | 0.9403 | 0.8550 | MN20160304_L02 | C03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 12.28 | 770.25 | 1075 | 1358 | 0.7915 | 0.5029 | MN20160304_L02 | H18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 14.50 | 770.25 | 1446 | 1497 | 0.9658 | 0.9287 | MN20160304_L02 | C03 |